Email this article Targeted Therapy: A New Approach for the Treatment of Locally Advanced Oropharyngeal Cancer
- Authors: Velsher L.Z.1,2, Kosmynin A.A.1, Byakhov M.Y.1,2, Duditskaya T.K.1,2, Reshetov D.N.1,2
-
Affiliations:
- Moscow State Medical and Dental University
- Cancer Center JSC "RZD"
- Issue: Vol 4, No 1 (2012)
- Pages: 82-85
- Section: Research Articles
- Submitted: 17.01.2020
- Published: 15.03.2012
- URL: https://actanaturae.ru/2075-8251/article/view/10638
- DOI: https://doi.org/10.32607/20758251-2012-4-1-82-85
- ID: 10638
Cite item
Abstract
Presented herein is a clinical study comprising 48 patients (42 men and 6 women) of working age (40-70 years), all of whom are suffering from locally advanced oropharyngeal cancer. A modern approach is applied to treat these patients, i.e., neoadjuvant targeted therapy, taking into account the biological profile of the tumor. The use of gefitinib causes an antitumor effect in 90.5% of cases as opposed to 56.5% when no drug is applied.
About the authors
L. Z. Velsher
Moscow State Medical and Dental University; Cancer Center JSC "RZD"
Email: kosmos-83@list.ru
Россия
A. A. Kosmynin
Moscow State Medical and Dental University
Author for correspondence.
Email: kosmos-83@list.ru
Россия
M. Yu. Byakhov
Moscow State Medical and Dental University; Cancer Center JSC "RZD"
Email: kosmos-83@list.ru
Россия
T. K. Duditskaya
Moscow State Medical and Dental University; Cancer Center JSC "RZD"
Email: kosmos-83@list.ru
Россия
D. N. Reshetov
Moscow State Medical and Dental University; Cancer Center JSC "RZD"
Email: kosmos-83@list.ru
Россия
References
- Stewart B.W., Kleihues P.E. World Cancer Report. Lyon, France: Internat. Agency Res. on Cancer Press, 2003.
- Venmorven J.B. // J. Clin. Oncol. 2007. V. 25. № 16. Р 2171-2177.
- Chissov V.I., Starinsky V.V., Petrova G.V. Sostoyanie onkologicheskoy pomoschi naseleniyu Rossii v 2007 godu (The state of cancer care of the population of Russia in 2007). M.: FGI “MCRI of P.A.Herzen” Ministry of Health and Social Development of Russia, 2008. P. 16.
- Novik A.A., Kamilova T.A., Tsygan V.N. // Issues on Oncology. 2003. № 6. P 695-703.
- Platinsky L.V., Bryuzgin V.V., Blumenberg A.G. // Rus. Med. Jour.. 2002. V. 10. № 24. P. 1116-1118.
- Podvyaznikov S.O., Byakhov M.Y. // Current oncology. 2002. V. 4. № 3. P 126-130.
- Pignon J.P., Bourhis J. // Lancet. 2000. V. 355. P 949-955.
- Forastiere A.A. // Semin. Oncol. 1994. V. 21. (Suppl. 8). P. 49-52.
- Manzione L., Caponigro F., Massa E. // Proc. Amer. Soc. Clin. Oncol. 1999. V. 18. P. 398a.
- Moiseenko V.M. // Practical oncology. 2002. № 4. P. 253-261.
- Kopnin B.P // Practical oncology. 2002. № 4. P 229-235.
- Paez J.G., Janne P.A., Lee J.C. // Science. 2004. V. 304. P. 1497-1500.
- Rivera F., Garcia-Castano A., Vega N. // Expert. Rev. Anticancer Ther. 2009. V. 9. № 10. Р 1421-1428.
- Vermorken J.B., Mesia R., Rivera F. // N. Engl. J. Med. 2008. V. 359. № 11. Р 1116-1127.
- Grandis J.R., Melhem M.F., Gooding W.E. // J. Natl. Cancer Inst. 1998. V. 90. № 11. Р 824-828.
- Ono M., Kowano M. // Clin. Cancer Res. 2006. V. 12. P 7242-7251.
- Vernham G.A., Crowther J.A. // Clin. Otolaryngol. Allied Sci. 1994. V. 19. P. 120-124.
- Lynch T.J., Bell D.W., Sordella R. // N. Engl. J. Med. 2004. V. 350. P 2129-2139.
- Inoue A., Kobayashi K., Naemondo M. // Eur. J. Cancer 45 (Suppl. 1), 2009. (Abstract 9LBA).
- Lee J.S., Park K., Kim S.-W. // J. Trobac. Oncol. 4 (Suppl. 1). 2009. (Abstract PRS.4).
- Pao W., Miller V., Zakowski M. // Proc. Natl. Acad. Sci. USA. 2004. V. 101. P. 13306-13311.
- Mitsudomi T., Morita S., Yatabe Y. // Lancet Oncol. 2010. V. 11. № 2. Р 121-128.
- Albanell J., Rojo F., Averbuch S. // J. Clin. Oncol. 2002. V. 20. P 110-124.
- Korman D.B. Osnovy protivoopukholevoy khimioterapii (Basics of cancer chemotherapy). M.: Prakticheskaya meditsina, 2006. P. 282-283.
- Cohen J.// Br. J. Cancer. 2007. V. 96. № 3. P 408-416.
Supplementary files
